Elevated hepatocyte growth factor expression as an autocrine c‐Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells
2002 ◽
Vol 91
(10)
◽
pp. 923-930
◽
2011 ◽
Vol 29
(15_suppl)
◽
pp. 7531-7531
◽
1999 ◽
Vol 214
(1)
◽
pp. 92-100
◽
2002 ◽
Vol 278
(1)
◽
pp. 343-351
◽
2005 ◽
Vol 68
(4)
◽
pp. 1500-1510
◽